ENTITY
Kolon TissueGene

Kolon TissueGene (950160 KS)

13
Analysis
Health CareUnited States
Kolon TissueGene, Inc. operates as a biopharmaceutical company. The Company develops novel advanced orthopedic disorders cell therapies, novel cell and gene therapies drugs, and other related products. Kolon TissueGene offers services worldwide.
more
17 Oct 2017 13:38

TissueGene IPO Part 3 - More Fact Gathering from Yesterday's Press Meeting

It is time to decide on TissueGene Inc. (950160 KS) IPO. Its bookbuilding is actually taking place today and tomorrow. I know this is a very...

Logo
316 Views
Share
02 Oct 2017 16:28

TissueGene IPO Part 2 - Facts About Cartilage Regeneration & US Clinical Trial

TissueGene Inc. (950160 KS) is 'still' clearly saying that its Invossa (TG-C) has the following three significant features. Requires only a single...

Logo
443 Views
Share
21 Sep 2017 19:58

TissueGene IPO Part 1 - IPO Prospectus Summary

What is Korea's hottest stock now? I guess many investors will have SillaJen, Inc. (0908477D KS) in their mind when asked this question. SillaJen's...

Logo
652 Views
Share
x